,

Tanjina Kader1,2, Jia-Ren Lin1,2, Clemens Hug1

  • 1Laboratory of Systems Pharmacology, Harvard Medical School, Boston, MA, USA.

概括

卵巢癌的早期前体在输卵管中表现出免疫调节变化和染色体不稳定性. 这些分子变化推动了从免疫监测到抑制的进展,在高度血清性卵巢癌 (HGSOC) 中.